DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL Stock

Certificat

DE000ME7CYE2

Market Closed - Börse Stuttgart 12:59:37 2024-05-31 EDT
344 EUR -0.84% Intraday chart for DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL
1 month+2.89%
3 months+4.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 344 -0.84%
24-05-30 347 +0.25%
24-05-29 346.1 -0.15%
24-05-28 346.6 -0.30%
24-05-27 347.6 +0.37%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 12:59 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
Issuer Morgan Stanley
WKN ME7CYE
ISINDE000ME7CYE2
Date issued 2024-01-23
Cap 400 $
Last trading day 2024-09-20
Maturity 2024-09-20 (110 Days)
Parity 1 : 1
Emission price 322.1
Emission volume N/A
Payment day 2024-09-27
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 6.564 %
Sideways yield 6.473 %
Sideways yield pa 21.10 %
Outperformance point 428.1 $
Break even 375.68 €
Highest since issue 348
Lowest since issue 315
Spread 0.08
Spread %0.02%
Distance Cap 2.12 $
Distance Cap %+0.53%
Max. earning 22.42
Max. earning % 6.473 %

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus